Innovation drives the healthcare industry and jointly draws a new blueprint for technology and finance

　　Shanghai Pudong Development Silicon Valley Bank released the "Trends in capital markets in China’s healthcare industry – 2023 Annual Report"

　　This year, the "five major articles" of technology finance, green finance, inclusive finance, pension finance, and digital finance were officially included in the "Government Work Report", outlining a clear blueprint for the development of the financial industry. The health care industry is not only related to the well-being of the people, but also to the prosperity of the country as a whole. The pace of innovation and development is closely linked to the deep participation and precise support of finance.

　　Shanghai Pudong Development Silicon Valley Bank, as the first science and technology innovation bank in China to focus on the innovation economy, has released the "2023 Annual Report on Capital Markets Trends in China’s Healthcare Industry" (hereinafter referred to as the "Report") with years of experience in the medical and health industry. The report focuses on biopharmaceuticals, medical apparatus, diagnostics/tools, R & D and production outsourcing services, pharmaceutical services and other tracks, reviewing the development trajectory of China’s healthcare industry in 2023 from different dimensions such as investment, mergers and acquisitions and IPO, and looking forward to the development trend of 2024, aiming to provide entrepreneurs, investors and decision makers with comprehensive and in-depth insights to jointly explore the future development of the healthcare industry.

　　During the adjustment period of the medical and health industry, capital returns to rationality

　　2023 is undoubtedly a turning point year for Chinese life sciences and healthcare companies. SPD Silicon Valley Bank observed that after nearly two decades of rapid growth, the healthcare industry reached the peak of investment and financing in 2021. However, in the following years, the industry gradually entered a cyclical adjustment stage at the capital level, and both the number and amount of investment and financing declined. Despite this, starting from the second quarter of 2023, the number of transactions in the healthcare industry gradually stabilized, showing a positive recovery trend. The investment of capital and talent in the past ten years has significantly enhanced the strength of Chinese healthcare companies in innovation and research and development, and the exploration of commercialization and going overseas has also achieved milestones. These developments not only reflect the transformation of our country’s medical and health enterprises from following innovation to independent innovation, but also show the trend of their products gradually moving towards internationalization, and at the same time, there are more diversified choices in the exit path.

　　Deeply empowered medical industry, long-term support results

　　SPD Silicon Valley Bank has always maintained a positive empowering attitude towards China’s medical and health industry, firmly optimistic about and supporting medical enterprises with core competitiveness. Relying on professional financial services and years of knowledge accumulation of the medical industry, the bank has provided all-round support for these enterprises to help them achieve leapfrog development. In 2023, the bank continued to lay out leading projects in the field of biomedicine, covering vaccines, cell gene therapy, proteomics and other innovative fields, and deeply excavated innovative device companies with high innovation barriers and segmentation ceilings. During this period, the bank issued billions of yuan of letters of intent to medical customers, and existing credit medical customers were also very popular in the market. In 2023 alone, it leveraged more than 8.30 billion yuan in equity financing.

　　Since 2019, SPD Silicon Valley Bank has had medical customers successfully land on the Sino-US capital markets every year, and 2023 is no exception. During this year, the bank successfully helped biomedical customers list in the US stock market, and promoted the listing of skin science research and hair companies in Hong Kong stocks. In addition, many customers have completed authorized overseas transactions or made breakthroughs in their own core pipelines and businesses. It is worth mentioning that the bank’s medical customers have performed well in the industry, ranking 96 times in authoritative lists, such as "2023 Global Unicorn List", "2023 Future Medical 100" and "Zero2IPO V50", etc., fully demonstrating its leading position in the industry.

　　Deep in five major articles, exploring new directions for financial development

　　Shanghai Pudong Development Silicon Valley Bank actively responded to the national strategy, guided by the "five major articles", actively gave play to its professional advantages in the financial field, and supported its implementation with practical actions. In addition to focusing on the medical and health industry, the bank has also paid attention to the development process of the dual-carbon field for a long time. It released the "China Science and Technology Entrepreneurs’ Dual-Carbon Road 2023 Mid-Year Report", which aims to deeply explore the development trends and trends in this field, promote technological innovation, empower the high-quality development of the industry, and is committed to the promotion and implementation of green finance.

　　In the future, SPD Silicon Valley Bank will continue to deepen the "five major articles" and explore new directions for financial development. The bank will actively explore innovative financial products, unswervingly promote the development of green finance, continuously optimize service processes, and accelerate the process of digital transformation to continuously improve the efficiency and security of financial services. Through unremitting efforts and continuous innovation, SPD Silicon Valley Bank will contribute more to China’s modern economic system construction, and jointly write a new chapter in the integrated development of finance and various fields.

　　　[Disclaimer] This article only represents the views of a third party and does not represent the position of Hexun.com. Investors operate accordingly, and please bear the risk.